Ipamorelin, a selective pentapeptide growth hormone secretagogue derived from GHRP-1, was originally developed by Novo Nordisk and represents the first highly selective growth hormone-releasing peptide with minimal effects on other pituitary hormones
The Perfect B Stacking Compatibility Chart The following table comes directly from the stacking guides in Perfect Bs patient protocol documents
For gut-specific use, oral may be adequate
Trnka, D
Common Contraindications Active or recent cancer (BPC-157 and TB-500 angiogenesis concern), Wilson's disease or other copper metabolism disorders (GHK-Cu component), pregnancy or breastfeeding (no safety data for any component), and competitive sport at WADA-tested levels (BPC-157 and TB-500 are listed under WADA category S0 Unapproved Substances) are commonly cited reasons not to research KLOW
[17] Mokhtare M, Alimoradzadeh R, Agah S, Mirmiranpour H, Khodabandehloo N